RBM5/Luca-15/H37 Regulates Fas Alternative Splice Site Pairing after Exon Definition

Molecular Cell

Volumn 32, Issue 1, 2008, Pages 81-95

  Bonnal, Sophie ^a   Martínez, Concepción ^a   Förch, Patrik ^d   Bachi, Angela ^d   Wilm, Matthias ^d   Valcárcel, Juan ^a,b,c  

^a CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^b INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

HUMDISEASE; RNA

Indexed keywords

H37 PROTEIN; LUCA 15 PROTEIN; RIBONUCLEOPROTEIN; RNA BINDING MOTIF PROTEIN 5; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BASE PAIRING; CONTROLLED STUDY; EXON; HUMAN; HUMAN CELL; INTRON; MOLECULAR MECHANICS;

ALTERNATIVE SPLICING; ANTIGENS, CD95; APOPTOSIS; BASE SEQUENCE; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELL CYCLE PROTEINS; DNA; DNA-BINDING PROTEINS; EXONS; GENES, TUMOR SUPPRESSOR; HELA CELLS; HUMANS; INTRONS; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROTEIN STRUCTURE, TERTIARY; RIBONUCLEOPROTEIN, U5 SMALL NUCLEAR; RIBONUCLEOPROTEINS; RNA SPLICE SITES; RNA-BINDING PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 53149145051     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2008.08.008     Document Type: Article

References (50)

1. Ast G. The alternative genome. Sci. Am. 292 (2005) 40-47
2. Behzadnia N., Hartmuth K., Will C.L., and Luhrmann R. Functional spliceosomal A complexes can be assembled in vitro in the absence of a penta-snRNP. RNA 12 (2006) 1738-1746
3. Ben-Dov C., Hartmann B., Lundgren J., and Valcarcel J. Genome-wide analysis of alternative pre-mRNA splicing. J. Biol. Chem. 283 (2008) 1229-1233
4. Berget S.M. Exon recognition in vertebrate splicing. J. Biol. Chem. 270 (1995) 2411-2414
5. Blencowe B.J. Alternative splicing: new insights from global analyses. Cell 126 (2006) 37-47
6. Callebaut I., and Mornon J.P. OCRE: a novel domain made of imperfect, aromatic-rich octamer repeats. Bioinformatics 21 (2005) 699-702
7. Cascino I., Fiucci G., Papoff G., and Ruberti G. Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J. Immunol. 154 (1995) 2706-2713
8. Chang D.W., Xing Z., Pan Y., Algeciras-Schimnich A., Barnhart B.C., Yaish-Ohad S., Peter M.E., and Yang X. c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J. 21 (2002) 3704-3714
9. Cheng J., Zhou T., Liu C., Shapiro J.P., Brauer M.J., Kiefer M.C., Barr P.J., and Mountz J.D. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263 (1994) 1759-1762
10. Corsini L., Bonnal S., Basquin J., Hothorn M., Scheffzek K., Valcarcel J., and Sattler M. U2AF-homology motif interactions are required for alternative splicing regulation by SPF45. Nat. Struct. Mol. Biol. 14 (2007) 620-629
11. Deckert J., Hartmuth K., Boehringer D., Behzadnia N., Will C.L., Kastner B., Stark H., Urlaub H., and Luhrmann R. Protein composition and electron microscopy structure of affinity-purified human spliceosomal B complexes isolated under physiological conditions. Mol. Cell. Biol. 26 (2006) 5528-5543
12. Drabkin H.A., West J.D., Hotfilder M., Heng Y.M., Erickson P., Calvo R., Dalmau J., Gemmill R.M., and Sablitzky F. DEF-3(g16/NY-LU-12), an RNA binding protein from the 3p21.3 homozygous deletion region in SCLC. Oncogene 18 (1999) 2589-2597
13. Edamatsu H., Kaziro Y., and Itoh H. LUCA15, a putative tumour suppressor gene encoding an RNA-binding nuclear protein, is down-regulated in ras-transformed Rat-1 cells. Genes Cells 5 (2000) 849-858
14. Förch P., Puig O., Kedersha N., Martinez C., Granneman S., Seraphin B., Anderson P., and Valcarcel J. The apoptosis-promoting factor TIA-1 is a regulator of alternative pre-mRNA splicing. Mol. Cell 6 (2000) 1089-1098
15. Gama-Carvalho M., Krauss R.D., Chiang L., Valcarcel J., Green M.R., and Carmo-Fonseca M. Targeting of U2AF65 to sites of active splicing in the nucleus. J. Cell Biol. 137 (1997) 975-987
16. Guth S., Tange T.O., Kellenberger E., and Valcarcel J. Dual function for U2AF(35) in AG-dependent pre-mRNA splicing. Mol. Cell. Biol. 21 (2001) 7673-7681
17. House A.E., and Lynch K.W. An exonic splicing silencer represses spliceosome assembly after ATP-dependent exon recognition. Nat. Struct. Mol. Biol. 13 (2006) 937-944
18. House A.E., and Lynch K.W. Regulation of alternative splicing: more than just the ABCs. J. Biol. Chem. 283 (2008) 1217-1221
19. Ibrahim E.C., Schaal T.D., Hertel K.J., Reed R., and Maniatis T. Serine/arginine-rich protein-dependent suppression of exon skipping by exonic splicing enhancers. Proc. Natl. Acad. Sci. USA 102 (2005) 5002-5007
20. Izquierdo J.M., Majos N., Bonnal S., Martinez C., Castelo R., Guigo R., Bilbao D., and Valcarcel J. Regulation of Fas alternative splicing by antagonistic effects of TIA-1 and PTB on exon definition. Mol. Cell 19 (2005) 475-484
21. Krueger A., Baumann S., Krammer P.H., and Kirchhoff S. FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis. Mol. Cell. Biol. 21 (2001) 8247-8254
22. Krueger A., Schmitz I., Baumann S., Krammer P.H., and Kirchhoff S. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J. Biol. Chem. 276 (2001) 20633-20640
23. Lerman M.I., and Minna J.D. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res. 60 (2000) 6116-6133
24. Lim S.R., and Hertel K.J. Commitment to splice site pairing coincides with A complex formation. Mol. Cell 15 (2004) 477-483
25. Liu C., Cheng J., and Mountz J.D. Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation. Biochem. J. 310 (1995) 957-963
26. Maarabouni M.M., and Williams G.T. The antiapoptotic RBM5/LUCA-15/H37 gene and its role in apoptosis and human cancer: research update. ScientificWorldJournal 6 (2006) 1705-1712
27. Masuda S., Das R., Cheng H., Hurt E., Dorman N., and Reed R. Recruitment of the human TREX complex to mRNA during splicing. Genes Dev. 19 (2005) 1512-1517
28. Micheau O., Thome M., Schneider P., Holler N., Tschopp J., Nicholson D.W., Briand C., and Grutter M.G. The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J. Biol. Chem. 277 (2002) 45162-45171
29. Mourtada-Maarabouni M., Sutherland L.C., and Williams G.T. Candidate tumour suppressor LUCA-15 can regulate multiple apoptotic pathways. Apoptosis 7 (2002) 421-432
30. Mourtada-Maarabouni M., Sutherland L.C., Meredith J.M., and Williams G.T. Simultaneous acceleration of the cell cycle and suppression of apoptosis by splice variant delta-6 of the candidate tumour suppressor LUCA-15/RBM5. Genes Cells 8 (2003) 109-119
31. Mourtada-Maarabouni M., Keen J., Clark J., Cooper C.S., and Williams G.T. Candidate tumor suppressor LUCA-15/RBM5/H37 modulates expression of apoptosis and cell cycle genes. Exp. Cell Res. 312 (2006) 1745-1752
32. Oh J.J., Grosshans D.R., Wong S.G., and Slamon D.J. Identification of differentially expressed genes associated with HER-2/neu overexpression in human breast cancer cells. Nucleic Acids Res. 27 (1999) 4008-4017
33. Oh J.J., West A.R., Fishbein M.C., and Slamon D.J. A candidate tumor suppressor gene, H37, from the human lung cancer tumor suppressor locus 3p21.3. Cancer Res. 62 (2002) 3207-3213
34. Oh J.J., Razfar A., Delgado I., Reed R.A., Malkina A., Boctor B., and Slamon D.J. 3p21.3 tumor suppressor gene H37/Luca15/RBM5 inhibits growth of human lung cancer cells through cell cycle arrest and apoptosis. Cancer Res. 66 (2006) 3419-3427
35. Ramaswamy S., Ross K.N., Lander E.S., and Golub T.R. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33 (2003) 49-54
36. Rintala-Maki N.D., and Sutherland L.C. LUCA-15/RBM5, a putative tumour suppressor, enhances multiple receptor-initiated death signals. Apoptosis 9 (2004) 475-484
37. Rintala-Maki N.D., Abrasonis V., Burd M., and Sutherland L.C. Genetic instability of RBM5/LUCA-15/H37 in MCF-7 breast carcinoma sublines may affect susceptibility to apoptosis. Cell Biochem. Funct. 22 (2004) 307-313
38. Rintala-Maki N.D., Goard C.A., Langdon C.E., Wall V.E., Traulsen K.E., Morin C.D., Bonin M., and Sutherland L.C. Expression of RBM5-related factors in primary breast tissue. J. Cell. Biochem. 100 (2007) 1440-1458
39. Roesler J., Izquierdo J.M., Ryser M., Rosen-Wolff A., Gahr M., Valcarcel J., Lenardo M.J., and Zheng L. Haploinsufficiency, rather than the effect of an excessive production of soluble CD95 (CD95{Delta}TM), is the basis for ALPS Ia in a family with duplicated 3′ splice site AG in CD95 intron 5 on one allele. Blood 106 (2005) 1652-1659
40. Sharma S., Falick A.M., and Black D.L. Polypyrimidine tract binding protein blocks the 5′ splice site-dependent assembly of U2AF and the prespliceosomal E complex. Mol. Cell 19 (2005) 485-496
41. Sharma S., Kohlstaedt L.A., Damianov A., Rio D.C., and Black D.L. Polypyrimidine tract binding protein controls the transition from exon definition to an intron defined spliceosome. Nat. Struct. Mol. Biol. 15 (2008) 183-191
42. Sutherland L.C., Edwards S.E., Cable H.C., Poirier G.G., Miller B.A., Cooper C.S., and Williams G.T. LUCA-15-encoded sequence variants regulate CD95-mediated apoptosis. Oncogene 19 (2000) 3774-3781
43. Sutherland L.C., Lerman M., Williams G.T., and Miller B.A. LUCA-15 suppresses CD95-mediated apoptosis in Jurkat T cells. Oncogene 20 (2001) 2713-2719
44. Sutherland L.C., Rintala-Maki N.D., White R.D., and Morin C.D. RNA binding motif (RBM) proteins: a novel family of apoptosis modulators?. J. Cell. Biochem. 94 (2005) 5-24
45. Timmer T., Terpstra P., van den Berg A., Veldhuis P.M., Ter Elst A., van der Veen A.Y., Kok K., Naylor S.L., and Buys C.H. An evolutionary rearrangement of the Xp11.3-11.23 region in 3p21.3, a region frequently deleted in a variety of cancers. Genomics 60 (1999) 238-240
46. Wang G.S., and Cooper T.A. Splicing in disease: disruption of the splicing code and the decoding machinery. Nat. Rev. Genet. 8 (2007) 749-761
47. Wei M.H., Latif F., Bader S., Kashuba V., Chen J.Y., Duh F.M., Sekido Y., Lee C.C., Geil L., Kuzmin I., et al. Construction of a 600-kilobase cosmid clone contig and generation of a transcriptional map surrounding the lung cancer tumor suppressor gene (TSG) locus on human chromosome 3p21.3: progress toward the isolation of a lung cancer TSG. Cancer Res. 56 (1996) 1487-1492
48. Welling D.B., Lasak J.M., Akhmametyeva E., Ghaheri B., and Chang L.S. cDNA microarray analysis of vestibular schwannomas. Otol. Neurotol. 23 (2002) 736-748
49. Will C.L., and Lührmann R. Spliceosome structure and function. In: Gesteland R.F., Cech T.R., and Atkins J.F. (Eds). The RNA World III (2005), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 369-400
50. Wistuba I.I., Lam S., Behrens C., Virmani A.K., Fong K.M., LeRiche J., Samet J.M., Srivastava S., Minna J.D., and Gazdar A.F. Molecular damage in the bronchial epithelium of current and former smokers. J. Natl. Cancer Inst. 89 (1997) 1366-1373